Evaluation of Parkinson s Patients and Primary Care Providers

Similar documents
Parkinson s Disease Update

III./3.1. Movement disorders with akinetic rigid symptoms

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

Parkinson s Disease. Sirilak yimcharoen

Optimizing Clinical Communication in Parkinson s Disease:

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Enhanced Primary Care Pathway: Parkinson s Disease

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

FOUNDATION OF UNDERSTANDING PARKINSON S DISEASE

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

The PD You Don t See: Cognitive and Non-motor Symptoms

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Faculty. Joseph Friedman, MD

Evaluation and Management of Parkinson s Disease in the Older Patient

Treatment of Parkinson s Disease: Present and Future

Comprehensive Approach to DLB Management

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

8/28/2017. Behind the Scenes of Parkinson s Disease

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

The PD You Don t See: Cognitive and Non-motor Symptoms

2/20/18. History of Parkinson s. What is happening in the brain? DOPAMINE! Epidemiology. Parkinson s Disease. It s much more than tremor

10th Medicine Review Course st July Prakash Kumar

U n i f i e d P a r k i n s o n s D i s e a s e R a t i n g S c a l e ( U P D R S )

Non-Motor Symptoms of Parkinson s Disease

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

PD: Key Treatment Considerations

Parkinson s Disease and other related movement disorders a video guide to diagnosis

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

Differential Diagnosis of Hypokinetic Movement Disorders

Parkinson s Disease. Patients will ask you. 8/14/2015. Objectives

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Unified Parkinson Disease Rating Scale (UPDRS)

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Headway Victoria Epilepsy and Parkinson s Centre

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

Clinical Features and Treatment of Parkinson s Disease

UNDERSTANDING PARKINSON S DISEASE

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn

Multiple choice questions: ANSWERS

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Corporate Medical Policy

Learnings from Parkinson s disease: Critical role of Biomarkers in successful drug development

PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING. Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH

Issues for Patient Discussion

Parkinson s Disease Update. Colleen Peach, RN, MSN, FNP Movement Disorders Clinic Emory University School of Medicine March 7, 2015

Chapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

PD AND FALLS J U MALLYA FALLS AWARENESS MEETING

Movement Disorders: A Brief Overview

Motor Fluctuations in Parkinson s Disease

UPDATE ON RESEARCH IN PARKINSON S DISEASE

Form B3L: UPDRS Part III Motor Examination 1

Prior Authorization with Quantity Limit Program Summary

Motor symptoms: Tremor: Score (total of four limbs) Absent 0 Symptom not present

Parkinson s Disease. Gillian Sare

Vague Neurological Disorders

Non-motor symptoms as a marker of. Michael Samuel

THE ART OF MEDICATION MANAGEMENT IN PARKINSON S DISEASE

Alison Charleston 1 st September 2016

Evaluations & CE. With Support From. Featured Speaker 1/20/2016. Conflict of Interest & Disclosure Statements

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

SHAKING UP THE WORLD OF PARKINSON S DISEASE

Parkinson's Disease KP Update

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff

The Parkinson s Disease Composite Scale

Chapter 20. Media Directory. Amyotrophic Lateral Sclerosis. Alzheimer s Disease. Huntington s Chorea. Multiple Sclerosis

Visualization and simulated animations of pathology and symptoms of Parkinson s disease

Appendix N: Research recommendations

PARKINSON S DISEASE 馬 萬 里. Chinese character for longevity (shou) Giovanni Maciocia

Early Clinical Features of Parkinson s Disease and Related Disorders. Dr. Alastair Noyce

Welcome and Introductions

Designing patient-centered clinical trials: Results of the MDIC project to use patient preference information to design clinical trials

La neurosonologia. Ecografia cerebrale e nuove applicazioni nelle malattie neurodegenerative. Nelle patologie degenerative e vascolari cerebrali

Parkinson s Disease Current Treatment Options

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y

Best Medical Treatments for Parkinson s disease

ID # COMPLETED: YES.. 1 DATE NO... 5 NEUROLOGICAL EXAM

9/26/18. Objectives. Disclosures. Parkinson s Disease Update Clinical and Operational Considerations

Welcome and Introductions

Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease

An Approach to Patients with Movement Disorders

Transcription:

Evaluation of Parkinson s Patients and Primary Care Providers 2018 Movement Disorders Half Day Symposium Elise Anderson MD Medical Co-Director, PBSI Movement Disorders 6/28/2018 1

Disclosures GE Speaker, DaTSCAN 6/28/2018 2

Outline PD diagnosis Motor and nonmotor symptoms Differential diagnosis Cases Treatment Options and the Impact on Other Chronic Diseases after the break! 6/28/2018 3

PD pathophysiology Degeneration of dopaminergic neurons in the brainstem substantia nigra Appearance of Lewy bodies in brainstem and other parts of the brain Lewy bodies contain alpha-synuclein and ubiquitin: markers of abnormal protein folding Mechanism: oxidative stress, mitochondria dysfunction, abnormal protein phosphorylation? Braaket al. NeurobiolAging 2003;24:197-211 6/28/2018 4

PD Cardinal Features Resting tremor Asymmetric rigidity Bradykinesia Postural instability Later in disease course Parkinsonian gait 6/28/2018 5

Tremor Resting tremor that improves with action 4-6 Hz Pill-rolling Asymmetric Worsens during anxiety/excitement or walking Hand tremor more common than foot as presenting feature Chin tremor 6/28/2018 6

PD tremor 6/28/2018 7

Rigidity Raised resistance during passive range of motion Cogwheeling Often more noticeable when tremor present Enhanced during mental task or contralateral limb movement 6/28/2018 8

Bradykinesia Slowness of movement Difficulty with fine motor tasks Buttoning Handwriting: micrographia Brushing teeth, washing hair On exam: FFM, RAM, heel tapping, or arm swing Rotator cuff injury 6/28/2018 9

Postural Instability Gradual onset of poor balance Increased risk of falls Retropulsion Pull test: can the patient catch herself Shuffling and narrow based gait En bloc turning Freezing With initiation or when encountering obstacles 6/28/2018 10

Parkinsonism Postural Instability 6/28/2018 11

PD Gait 6/28/2018 12

PD Clinical Diagnosis Queen s Square criteria: bradykinesia plus 1 of: Rigidity Rest tremor Postural instability, AND... Typical PD features: Unilateral onset Levodopa response Development of dyskinesia PLUS: absence of exclusion criteria... Gibb et al, J Neuro NeurosurgPsychiatry 1988. 6/28/2018 13

PD Exclusion criteria Exposure to drugs that can cause parkinsonism Cerebellar signs Corticospinal tract signs Eye movement abnormalities Severe dysautonomia Early moderate/severe gait disturbance or dementia History of encephalitis or recurrent head injury Evidence of severe subcortical white matter disease, hydrocephalus, or structural lesions on MRI 6/28/2018 14

Non-Motor Features of Preclinical ipd Strong evidence Constipation Olfactory deficit REM Sleep Behavior Disorder (RBD) Depression Weaker evidence Restless Legs Syndrome Apathy Fatigue Anxiety 6/28/2018 15

Dx of PD: premotor and motor phases Parkinsonsed.com 6/28/2018 16

Non-Motor Features in ipd Autonomic symptoms Bladder disturbances: nocturia, urgency, frequency Sweating Orthostatic hypotension Sexual dysfunction Dry eyes GI Symptoms Sialorrhea Dysphagia Constipation Chauduri, Lancet Neurol. 2006 6/28/2018 17

Non-Motor Features in ipd Neuropsychiatric symptoms Depression, anxiety, anhedonia Attention deficit Psychosis Dementia Confusion Sleep disorders RLS, periodic limb movements REM sleep behavior disorder Excessive daytime somnolence Insomnia Sleep disordered breathing Chauduri, Lancet Neurol. 2006 6/28/2018 18

Imaging: DaTSCAN SPECT scan (single-photon emission CT) DaT uptake (dopamine transporter) Abnormal if decrease in striatal binding FDA approved in 2011 to distinguish ET vs. PD Useful to distinguish PD from medication induced or vascular parkinsonism, identify atypical presentations of PD Not useful to distinguish ipd from PD-plus or to stage disease severity Catafau AM, Tolosa E. Mov Disord 2004;19:1175 1182. 6/28/2018 19

Imaging: DaTSCAN (a) healthy age-matched control subject (b) asymptomatic carrier of a mutation in LRRK2 Stoessl AJ, Brooks DJ, et al. Mov Disord 2011; 26:968-978. 20

When to refer? Early! We can help confirm diagnosis, establish team care, connect patient with resources If symptoms are bothersome, I recommend initiating treatment (more on that next) at the same time as referral Med response confirms diagnosis 6/28/2018 21

Case #1, Pt JL 57 year old man presenting with RUE tremor Tremor is noticeable at rest, improves with action No other complaints except stiff R shoulder PD ROS: +anosmia, constipation, RBD almost hit his wife in his sleep a few times Exam: Motor: R>L rest tremor, generalized bradykinesia with slowed spontaneous movements on L. Normal foot taps. Gait: sl lean to R, R>L tremor, mild stoop narrow base 6/28/2018 22

Pt JL, con t Impression: suspect ipd Plan: start rotigotine patch, PT referral, check MRI brain Next visit: normal MRI. Pt stopped patch due to foggy thinking, fatigue, hallucinations. PCP has started prozac for anxiety Plan: start artane for tremor Next visit: artane partially helps tremor but with brain fog and dry mouth Tremor is worse, pt is working full time Plan: start sinemet 25/100 TID 6/28/2018 23

Pt JL, con t Next visit: tremor better, but pt has more fatigue esp right after taking sinemet, and more apathy, anxiety, constipation and fatigue 18 months later: more tremor responding to more levodopa, but more fatigue, sedation, cognitive issues Discussion regarding retirement, disability app Start screening process for DBS 6/28/2018 24

Exam pre-dbs 6/28/2018 25

Exam post-dbs (same day, after initial programming) 6/28/2018 26